Schlagwortarchiv für: Publikationen: Prof. Dr. rer. nat. Volker Schirrmacher
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-07-23 / Biomedicines 2020 Jul;8(8)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-07-23 / Biomedicines 2020 Jul;8(8)2020-07-23 00:00:002021-11-15 19:51:32Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-06-30 / Expert Rev Anticancer Ther 2020 Aug;20(8):639-646
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-06-30 / Expert Rev Anticancer Ther 2020 Aug;20(8):639-6462020-06-30 00:00:002021-11-15 13:19:48Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-19 / Medicines (Basel) 2020 May;7(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-19 / Medicines (Basel) 2020 May;7(5)2020-05-19 00:00:002021-11-15 20:10:42Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-16 / Biomedicines 2020 Mar;8(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-16 / Biomedicines 2020 Mar;8(3)2020-03-16 00:00:002021-11-15 19:52:47Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-06 / Biomedicines 2020 Mar;8(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-06 / Biomedicines 2020 Mar;8(3)2020-03-06 00:00:002021-11-15 17:52:40New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-30 / Biomedicines 2019 Aug;7(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-30 / Biomedicines 2019 Aug;7(3)2019-08-30 00:00:002021-11-15 13:22:59Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-12-10 / Int J Oncol 2019 Feb;54(2):407-419
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-12-10 / Int J Oncol 2019 Feb;54(2):407-4192018-12-10 00:00:002021-11-15 20:14:26From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-20 / Int J Mol Sci 2017 May;18(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-20 / Int J Mol Sci 2017 May;18(5)2017-05-20 00:00:002021-11-15 16:51:51Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-10-05 / Expert Opin Biol Ther 2015;15(12):1757-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-10-05 / Expert Opin Biol Ther 2015;15(12):1757-712015-10-05 00:00:002021-11-15 16:52:53Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-28 / Immunotherapy 2015;7(8):855-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-28 / Immunotherapy 2015;7(8):855-602015-05-28 00:00:002021-11-16 07:55:05Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report